<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03748407</url>
  </required_header>
  <id_info>
    <org_study_id>18-040</org_study_id>
    <nct_id>NCT03748407</nct_id>
  </id_info>
  <brief_title>Determination of Baseline Thyroid Status Values in French Adult Population</brief_title>
  <acronym>THYRBECK</acronym>
  <official_title>Determination of Baseline Thyroid Status Values</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to establish reference values in the general population from a
      Beckman Coulter DxI chemiluminescence assay.

      Indeed, the lack of harmonization of the methods of the dosage remains a major difficulty to
      optimize the management of patients with thyroid disease.

      This supplier has recently optimized its dosing kit according to the 3rd international
      standard of the WHO (IRB 81/565) for the TSH (Thyroid Stimulating Hormon).

      It is necessary to carry out a study of the distribution of the values of this TSH within our
      metropolitan population. The current data proposed by the supplier come from a study of a
      North American population.

      investigators propose to define usual values for thyroid status markers (TSH, FT4 [free
      thyroxine], FT3 [free triiodothyroxine]) from healthy EFS (French Blood Establishment) donors
      who meet the standard exclusion criteria for this type of study.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of the usual values of TSH</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of the usual values of TSH after assays on DxI automaton of the Beckman Company according to the standardization 3rd international standard (IRB 81/565)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determination of the usual values of FT4</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of the usual values of FT4 after assays on DxI automaton of the Beckman Company according to the standardization 3rd international standard (IRB 81/565)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determination of the usual values of FT3</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of the usual values of FT3 after assays on DxI automaton of the Beckman Company according to the standardization 3rd international standard (IRB 81/565)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>dosages in Healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Only one arm : healthy volunteer blood donors. Performing a blood test for the determination of parameters that explore thyroid status : only once.
Absence of other healthy volunteers group all healthy volunteers have a blood test performed in the same way.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dosages of Thyroid parameters</intervention_name>
    <description>Dosages of the following parameters: TSH, FT4 FT3, TGAb (Tyroglobulin antibody) , TPO Ab (ThyroPeroxydase Antibody)</description>
    <arm_group_label>dosages in Healthy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Donors (18-70 years old) volunteers at EFS

        Exclusion Criteria:

          -  pregnancy,

          -  known antecedents of thyroid diseases (goiter, nodule, hypo or hyperthyroidism),

          -  current antithyroid treatment (neomercazole [Thyrozol(r)], levothyroxyn LT4
             [levothyrox(r)], ...),

          -  cardiac treatment with amiodarone (cordarone(r)),

          -  injection of iodinated contrast medium less than 1 month old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>October 30, 2018</study_first_submitted>
  <study_first_submitted_qc>November 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <last_update_submitted>November 19, 2018</last_update_submitted>
  <last_update_submitted_qc>November 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

